New drug put to the heart test: BI 1015550 passes safety check in healthy volunteers
NCT ID NCT06107036
First seen Dec 26, 2025 · Last updated May 21, 2026 · Updated 16 times
Summary
This study checked whether a single dose of the experimental drug BI 1015550 affects the heart's electrical activity in 46 healthy adults aged 18 to 50. Participants received low and high doses of the drug, a placebo, and an active control (moxifloxacin) to compare effects. The main goal was to see if the drug causes any dangerous changes in heart rhythm, helping researchers decide if it is safe to test in patients with lung disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Quotient Sciences
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.